Exercise and Testosterone Therapy in Elderly Men With Physical Frailty

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2009

Study Completion Date

August 31, 2009

Conditions
Physical FrailtyHip FractureElective Hip ReplacementHypogonadism
Interventions
DRUG

Transdermal Testosterone gel (1%)

Transdermal testosterone replacement therapy with Androgel(TM). Daily application of gel at 5 mg, 7.5 gm, or 10 gm for six months. Target serum total testosterone level between 500-900 ng/dl.

BEHAVIORAL

Supervised exercise training

Supervised exercise training performed on site at academic medical center exercise facility. Exercise training consisted of 2 months of flexibility, balance, treadmill walking, and physical therapy-type exercises, followed by 4 months of progressive resistance training.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Solvay Pharmaceuticals

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00345969 - Exercise and Testosterone Therapy in Elderly Men With Physical Frailty | Biotech Hunter | Biotech Hunter